Status:
COMPLETED
Exisulind Prior to Radical Prostatectomy
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Prostatic Neoplasms
Eligibility:
MALE
40+ years
Phase:
PHASE2
Brief Summary
This trial will compare no treatment to exisulind therapy. Patients enrolled on the treatment arm will begin treatment 4 weeks prior to the scheduled date of surgical removal of the prostate and will ...
Eligibility Criteria
Inclusion
- Males 40 years of age and older with prostate cancer who are scheduled to undergo surgical removal of the prostate at Mayo Clinic Rochester, Mayo Clinic Jacksonville, or Mayo Clinic Arizona may be eligible for this protocol.
Exclusion
Key Trial Info
Start Date :
April 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2007
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT00166478
Start Date
April 1 2002
End Date
October 1 2007
Last Update
January 28 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905